Calling the situation “untenable” and “unacceptable,” a powerful US senator has given the CEO of Philips North America a deadline to hand over information about a recent high-risk class I recall of the company’s sleep and ventilator devices.
Royal Philips initiated the recall on 14 June because sound abatement foam used in certain bi-level positive airway pressure (BiPAP),...